IP Library › Granted Patent US 12,357,812
Granted Patent B2
US 12,357,812 · App. 17/579,064 · Granted Jul 15, 2025

Lead construction including alignable marker elements

Inventors: Jay T. Rassat (Otsego, MN); Varun Bhatia (Minneapolis, MN); Kendall Emfield (Excelsior, MN); Ryan Lahm (Lino Lakes, MN); Alan Cheng (Minneapolis, MN); Douglas S. Hine (Forest Lake, MN); Kristin M. Johnson (Circle Pines, MN); Gregory N. Nesseth (Forest Lake, MN); Jonathan E. Baxter (Fridley, MN); Daniel W. Celotta (Circle Pines, MN); Stephen A. Howard (Forest Lake, MN); Nathan A. Grenz (North Oaks, MN); Brian P. Colin (Anoka, MN); Ronald A. Drake (St. Louis Park, MN); Juan Meng (Shanghai, CN); Hongyang Lu (Shanghai, CN)
Assignee: Medtronic, Inc.
A61N1/05B33Y10/00B33Y30/00B33Y80/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,357,812
App. No.
17/579,064
Granted
Jul 15, 2025
Kind
B2
Abstract

Implantable apparatus includes two or more alignable marker elements, and systems and methods for manufacturing such implantable apparatus, and methods to utilize such implantable apparatus. For example, the implantable apparatus may include a first alignable marker element and a second alignable marker element that may be used to ensure proper alignment with a target site.

Claims (20)

1. An implantable apparatus comprising:

a body defining a distal end region extending along a distal end region axis; and

two alignable marker elements coupled to the body within the distal end region, wherein each of the two alignable marker elements defines a complementary shape that complements the other alignable marker element such that, when the distal end region is viewed axially, the two alignable marker elements form a fiducial shape indicative of acceptable alignment of the distal end region for positioning at a target site.

2. The apparatus of claim 1 , wherein the two alignable marker elements are at least one of radiopaque and viewable when located within a patient's heart using fluoroscopy and echogenic and viewable when located within a patient's heart using ultrasound.

3. The apparatus of claim 1 , wherein the complementary shape of each of the two alignable marker elements is at least a portion of a circle and the fiducial shape is at least a portion of a single circle.

4. The apparatus of claim 3 , wherein the complementary shape of each of the two alignable marker elements is a circle or a semicircle and the fiducial shape is a single circle.

5. The apparatus of claim 1 , wherein each of the two alignable marker elements defines a different size than each other.

6. The apparatus of claim 5 , wherein a first alignable marker element of the two alignable marker elements defines a first length along the distal end region axis and a second alignable marker element of the two alignable marker elements defines a second length along the distal end region axis, wherein the first length is greater than the second length.

7. The apparatus of claim 5 , wherein each of the two alignable marker elements defines a different diameter than each other.

8. The apparatus of claim 7 , wherein the complementary shape of each of the two alignable marker elements comprises a plurality of portions of circle and the fiducial shape is a near-complete portion of a single circle defining a gap, wherein the gap is indicative of deflection direction of the body.

9. The apparatus of claim 8 , wherein a first alignable marker element of the two alignable marker elements comprises a first number of portions of the circle and a second alignable marker element of the two alignable marker elements a second number of portions of the circle, wherein the first number is greater than the second number.

10. The apparatus of claim 1 , further comprising at least one additional alignable marker element that defines another complementary shape that complements the two alignable marker elements such that, when the distal end region is viewed axially, the two alignable marker elements and the at least one additional alignable marker element form the fiducial shape indicative of acceptable alignment of the distal end region for positioning at the target site.

11. The apparatus of claim 10 , wherein the at least one additional alignable marker element defines a different size than at least one of the two alignable marker elements, wherein, when the distal end region is viewed axially, the two alignable marker elements and the at least one additional alignable marker element form a non-alignment fiducial shape indicative of unacceptable alignment of the distal end region.

12. The apparatus of claim 1 , wherein the two alignable marker elements define a coil extending along the distal axis, wherein, when the distal end region is viewed radially, a minimum length between the two alignable marker elements is indicative of acceptable alignment of the distal end region for positioning at the target site.

13. The apparatus of claim 1 , further comprising at least one extension member coupled to and extending between the two alignable marker elements.

14. The apparatus of claim 1 , wherein the body is a delivery catheter or a lead.

15. The apparatus of claim 1 , further comprising a fixation element coupled to the distal end region of the body to couple the body to the target site.

16. An implantable apparatus comprising:

a body defining a distal end region extending along a distal end region axis; and

an alignable marker element coupled to the body within the distal end region defining a directionally indicative shape that, when the distal end region is viewed axially, is indicative of the direction of the distal end region away from a target site.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 21, 2022
From: RASSAT, JAY T.; BHATIA, VARUN; EMFIELD, KENDALL; LAHM, RYAN; CHENG, ALAN; HINE, DOUGLAS S.; JOHNSON, KRISTIN M.; NESSETH, GREGORY N.; BAXTER, JONATHAN E.; CELOTTA, DANIEL W.; HOWARD, STEPHEN A.; GRENZ, NATHAN A.; COLIN, BRIAN P.; DRAKE, RONALD A.; MENG, JUAN; LU, HONGYANG
To: MEDTRONIC, INC.
Reel/Frame 059055/0338 →
Continuity (3)
Provisional Application 63139662 · Jan 20, 2021
Provisional Application 63139661 · Jan 20, 2021
Related Publication 20220226636A1 · Jul 21, 2022
References Cited (88)
US 2764148A · Sheldon · 1956 [cited by applicant]
US 3485234A · Stevens · 1969 [cited by applicant]
US 5871475A · Frassica · 1999 [cited by applicant]
US 6187130B1 · Berard · 2001 [cited by applicant]
US 6548010B1 · Stivland · 2003 [cited by applicant]
US 6591472B1 · Noone et al. · 2003 [cited by applicant]
US 7306617B2 · Majercak · 2007 [cited by applicant]
US 7833218B2 · Lunn et al. · 2010 [cited by applicant]
US 7909033B2 · Faram · 2011 [cited by applicant]
US 8118827B2 · Duerig et al. · 2012 [cited by applicant]
US 8509916B2 · Byrd et al. · 2013 [cited by applicant]
US 8744595B2 · Tronnes · 2014 [cited by examiner]
US 9002496B2 · Elsey · 2015 [cited by applicant]
US 9043191B2 · Grady et al. · 2015 [cited by applicant]
US 9974887B2 · Eversull et al. · 2018 [cited by applicant]
US 10254499B1 · Cohen et al. · 2019 [cited by applicant]
US 10327862B2 · Lubinski · 2019 [cited by applicant]
US 10442175B2 · Schlachter · 2019 [cited by applicant]
US 10548355B2 · Volpis et al. · 2020 [cited by applicant]
US 10610666B2 · Stern · 2020 [cited by applicant]
US 10751507B2 · Palmer et al. · 2020 [cited by applicant]
US 11160952B2 · Bridgeman · 2021 [cited by applicant]
US 11707332B2 · Bell · 2023 [cited by examiner]
US 20040002677A1 · Gentsler · 2004 [cited by applicant]
US 20070005041A1 · Frassica et al. · 2007 [cited by applicant]
US 20070060863A1 · Goeken et al. · 2007 [cited by applicant]
US 20080262472A1 · Lunn et al. · 2008 [cited by applicant]
US 20120149985A1 · Frassica et al. · 2012 [cited by applicant]
US 20140361460A1 · Mark · 2014 [cited by applicant]
US 20150217517A1 · Karpas et al. · 2015 [cited by applicant]
US 20160096323A1 · Fry et al. · 2016 [cited by applicant]
US 20160101262A1 · Root et al. · 2016 [cited by applicant]
US 20160184233A1 · Palomar-Moreno et al. · 2016 [cited by applicant]
US 20160207220A1 · Hack et al. · 2016 [cited by applicant]
US 20170156750A1 · Root · 2017 [cited by applicant]
US 20170182290A1 · Stern · 2017 [cited by applicant]
US 20170189553A1 · Hunter · 2017 [cited by applicant]
US 20170259506A1 · Ho et al. · 2017 [cited by applicant]
US 20180036123A1 · Costello · 2018 [cited by applicant]
US 20180065320A1 · Tyler · 2018 [cited by applicant]
US 20180104472A1 · Govea · 2018 [cited by examiner]
US 20180117855A1 · Girou et al. · 2018 [cited by applicant]
US 20180141274A1 · Fink et al. · 2018 [cited by applicant]
US 20180168687A1 · Drake et al. · 2018 [cited by applicant]
US 20180250498A1 · Stern · 2018 [cited by applicant]
US 20180254099A1 · Beydoun et al. · 2018 [cited by applicant]
US 20180257444A1 · Hack · 2018 [cited by examiner]
US 20180289925A1 · Palmer et al. · 2018 [cited by applicant]
US 20180370117A1 · Gardiner et al. · 2018 [cited by applicant]
US 20190002625A1 · Jiang et al. · 2019 [cited by applicant]
US 20190209080A1 · Gullotti et al. · 2019 [cited by applicant]
US 20190240456A1 · Pokorny et al. · 2019 [cited by applicant]
US 20190351185A1 · Assouline et al. · 2019 [cited by applicant]
US 20200080237A1 · Vogt et al. · 2020 [cited by applicant]
US 20200093505A1 · Sinelnikov et al. · 2020 [cited by applicant]
US 20200230397A1 · Li · 2020 [cited by examiner]
US 20210122115A1 · Ramos · 2021 [cited by applicant]
US 20210154473A1 · Pobiel · 2021 [cited by examiner]
US 20210236767A1 · Warnock, Jr. et al. · 2021 [cited by applicant]
US 20210298730A1 · Baxter et al. · 2021 [cited by applicant]
US 20220032002A1 · Baxter et al. · 2022 [cited by applicant]
US 20220032003A1 · Baxter et al. · 2022 [cited by applicant]
US 20220032537A1 · Baxter et al. · 2022 [cited by applicant]
US 20220233814A1 · Mullins · 2022 [cited by applicant]
CA 2998126 · 2018 [cited by applicant]
CN 109715244 · 2019 [cited by applicant]
EP 1053039 · 2000 [cited by applicant]
KR 101863192 · 2018 [cited by applicant]
WO 2014172545 · 2014 [cited by applicant]
WO 2016168505 · 2016 [cited by applicant]
WO 2019070899 · 2019 [cited by applicant]
WO WO2022236067A1 · 2022 [cited by examiner]
International Preliminary Report on Patentability for PCT Application No. PCT/US2021/024640 dated Oct. 13, 2022, 10 pages. [cited by applicant]
Ascend Medical Technologies, “Design Guidelines for 3D X-Fusion Technology”, ascendmedtech.com/design-guidelines, retrieved Oct. 25, 2019, 3 pages. [cited by applicant]
Ascend Medical Technologies, “Engineering Capabilities”, ascendmedtech.com/design-guidelines, retrieved Oct. 25, 2019, 7 pages. [cited by applicant]
Baxter et al., U.S. Appl. No. 17/215,842, filed Mar. 29, 2021. [cited by applicant]
Dilberoglu et al., “Current trends and research opportunities in hybrid additive manufacturing”, The International Journal of Advanced Manufacturing Technology, 113, 2021, pp. 623-648. [cited by applicant]
Gardeski et al., U.S. Appl. No. 17/215,842, filed Mar. 29, 2021. [cited by applicant]
Gardeski et al., U.S. Appl. No. 63/001,832, filed Mar. 30, 2020. [cited by applicant]
Ramos et al., U.S. Appl. No. 17/081,815, filed Oct. 27, 2020. [cited by applicant]
Ramos et al., U.S. Appl. No. 62/927,092, filed Oct. 28, 2019. [cited by applicant]
Warnock Jr. et al., U.S. Appl. No. 17/162,101, filed Jan. 29, 2021. [cited by applicant]
Warnock Jr. et al., U.S. Appl. No. 62/970,561, filed Feb. 5, 2020. [cited by applicant]
International Search Report and Written Opinion from PCT/US2021/043795 dated Oct. 20, 2021, 14 pages. [cited by applicant]
International Search Report and Written Opinion prepared for International Application No. PCT/US2021/043794, mailed Nov. 23, 2021. 11 pages. [cited by applicant]
International Search Report and Written Opinion from PCT Application No. PCT/US2021/024640 dated Sep. 13, 2021, 17 pages. [cited by applicant]
International Search Report and Written Opinion in PCT Application No. PCT/US2022/012966, dated Jun. 13, 2022, 19 pages. [cited by applicant]
Office Action issued in China for Application No. 202180021033.2 dated Mar. 19, 2025 (10 pages). English translation included. [cited by applicant]